Jersey student leads project to recreate fatty liver disease
A Jersey student aims to better understand fatty liver disease by re-creating it in a dish. Millie-Rose Doolan, who grew up in St Brelade, has plans to use patient-donated liver samples to develop 3D tissue cultures that are derived from stem, progenitor or induced pluripotent cells. Fatty liver disease, also known as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), is a chronic liver condition that is initiated by having too much fat in the liver. Ms Doolan, who is studying for her PhD at the University of Southampton, said: "By creating 3D organoids using patient tissue we can delve deeper into how the disease progresses and identify potential targets for treatment."
Global health problem
MASLD is significantly associated with central obesity, as well as conditions such as type 2 diabetes and heart and circulatory disease. It is estimated to affect up to one in five people in the UK, but rates are increasing with rising levels of metabolic diseases such as obesity.Ms Doolan said: "Fatty liver disease is a global health problem – latest figures suggest that up to 30% of the global adult population will be affected."The underlying biology of MASLD progression is unclear, and not all patients progress at the same rate or develop severe disease."
Currently, MASLD research is limited by a lack of experimental systems that replicate what happens in different humans. Some laboratory tests can recapitulate aspects of MASLD progression but there are significant differences to what happens in the human body or a given individual.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Times
an hour ago
- Times
Births, marriages and deaths: July 1, 2025
FOR the word of the LORD is right and true; he is faithful in all he does. Psalm 33.4 (NIV) Bible verses are provided by the Bible Society The University of Southampton at University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, hereby gives notice that it has applied to the secretary of state for Environment, Food and Rural Affairs for consent to conduct a trial of genetically modified Neisseria lactamica bacteria under section 111 of the Environmental Protection Act 1990. Doctors in the University of Southampton's controlled human infection group will inoculate healthy volunteers with genetically modified Neisseria lactamica in 'The GM-Nlac Study', part of a series of studies to inform the rational design of future vaccines. The proposed release will be conducted at the NIHR Southampton Clinical Research Facility at SO16 6YD between February 2026 – May 2031 (inclusive). The secretary of state will consider any representations made relating to risks to the environment posed by the release of these genetically modified organisms within a period that he shall specify in accordance with the Genetically Modified Organisms (Deliberate Release) Regulations 2002. The secretary of state will place information on this proposed GMO release on a public register within 12 days of receipt of the application. The public register can be inspected by contacting the GM Team in Defra at the address below. Information will also be placed on the web at The website will include details of how and when representations may be made in respect of the application. Inquiries on this public consultation should be directed to the address below: GM Team, Defra 2nd Floor, Seacole Building, 2 Marsham Street, London, SW1P 4DF. (e-mail: gm-regulation@
BBC News
3 days ago
- BBC News
Phage therapy: I found a bacteria-eating virus in my loo
I'm on the hunt for a microbial saviour – a type of virus that can treat infections rather than cause all know the viral bad guys – Covid, flu, norovirus, herpes, chicken pox, measles… the list goes there's a type of virus that's not interested in infiltrating our bodies, instead it preys on known as bacteria eaters, or bacteriophage, or commonly as them could give us new ways of treating infections, including superbugs that are becoming how to catch a killer?I've been promised it's surprisingly easy. The team at the Phage Collection Project sent me some vials to collect samples, along with a pair of gloves. All I need to do is hunt for some dirty water, the dirtier the better, dip the vials in and screw on the lid. I tried a couple of ponds, the juice from a worm-composting bin and then I needed my dirtiest sample. I didn't flush the toilet after a poo and left it for a couple of hours. I pop on a glove and hold my breath as I go in for the final sample. Strict hygiene instructions, including vigorous hand-washing, were followed, at all vials were packaged up for collection and then three days later I headed off to the University of Southampton to see what was inside."They were a bit dirty when I received them," phage scientist Michelle Lin tells me as we don our blue lab-coats and matching gloves to go into the Containment Level 2 microbiology grab my samples from the fridge, which look much clearer now they have been filtered of any… debris. "It's fine, it's needed," Michelle, who had the unpleasant job, reassures me. Filtering is the first step in looking for phage, next they get served dinner – a cocktail of yummy bacteria - to help them grow in comes the really cool bit – finding a useful phage. The scientists have been working with the local hospital to collect bacteria from patients with troublesome grabs a petri dish that's growing bacteria from a patient with a painful, urinary tract infection that keeps coming to my amazement – one of the phage I collected from my toilet was able to kill this infection in the lab."The way to see that the phage has infected bacteria is you get these zones where the bacteria are not growing and that's because they've been killed by the phage," says Michelle. You can see the leopard print pattern in the petri dish where the phage have been making light work of a bacterial infection that modern medicine was struggling to shift."As crazy as it sounds, well done to the toilet sample," says Michelle with great when I was offered the chance to name the phage, well of course it's the Gallagher-phage."Sounds amazing to me," says far this is all good fun in the laboratory, but could my phage ever be given to a patient?"Yes and I hope so," says associate professor Dr Franklin Nobrega as we look at images of my phage captured with an electron microscope. "Your phage, already in just 24 hours, we were able to get in a high concentration and able to be a very good killer, which means this is very promising for patients, so thank you," said Dr remind me of a moon lander – a big capsule on spindly legs – just instead of landing on the surface of the moon they use their legs to select their then hijack the bacteria and transform it into a mass-production factory for more phage, which burst out of their host, killing it in the process. There are pros and cons to phage. They reproduce as they go along so you don't need constant doses like you would with are also very picky eaters. You need a precise match between phage and the strain of bacteria you're trying to treat whereas antibiotics tend to kill everything good and bad. So it is harder to find the right phage, but if you do it comes with fewer side Nobrega tells me infected wounds are a "very good application" for phage because you can apply them directly to the injury, but they can also be inhaled via a nebuliser to treat lung infections or to target urinary tract infections "which is our target currently". Phage - the friendly virus Phage science may sound new and exciting, but it is actually a century old idea stemming from the discoveries of Felix d'Hérelle and Frederick Twort in the therapy was a branch of medicine and the idea was compelling. Even as late as the 1940s there was an active pharmaceutical industry in western countries trying to produce phage-therapy to defeat bacterial it was rapidly eclipsed by the wonder-drug of the 20th century."Antibiotics were working so well that most people said 'why bother'," says Dr Nobrega. Work on phage therapy continued in places like Georgia and there are individual accounts of it working wonders; but there hasn't been the same depth of medical research and clinical trials as there have for just as the initial success of antibiotics suppressed phage research, the failure of antibiotics is reigniting excitement at their than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's known as the "silent pandemic". By 2050, that figure is projected to reach 10 million a "antibiotic apocalypse" would mean common infections could kill again and undermine modern medicine. The drugs are also used to make organ transplants, open surgery and chemotherapy possible."The predictions around antibiotic resistance are very frightening, but the reality is we're seeing it now and it's only going to get worse," says Prof Paul Elkington, the director of the institute for medical innovation at the University of Southampton. He is also a doctor with a speciality in lung medicine and is already at the point where - after a year of treatment and turning to ever more toxic and less effective antibiotics - "in the end you have to have a conversation [and say] 'we can't treat this infection, we're really sorry'".He says we can't rely solely on antibiotics in the future and phage are a potential he warns the steps needed to get from the laboratory and into patients are "uncharted".Things are changing. Phage therapy is available in the UK on compassionate grounds when other treatments have failed. And the drugs regulator – The Medicines and Healthcare products Regulatory Agency – has published its first official rules to support the development of phage therapy."If one looks 15-20 years into the future, with the emerging methodologies, it's going to be possible for them to be much more widely available and for doctors to prescribe phage instead of antibiotics for some infections," says Prof you want to see if you can find a friendly virus too then The Phage Collection Project are launching their new sampling kits at the Summer Science Exhibition taking place this week at the Royal Society and through their website."Antimicrobial resistance is something that could affect all of us," says Esme Brinsden from the Phage Collection Project, "when the public get involved they may just find the next phage that can help treat and save a patient's life".Photography by the BBC's Emma Lynch
Times
6 days ago
- Times
How a plume of magma threatens to one day rip east Africa apart
Africa is being torn apart by a pulsing plume of magma rising from deep within the Earth that is set to slice off the continent's east coast to form a new ocean, researchers have found. A new ocean basin will gradually form in a low-lying region of Ethiopia and, in several million years' time, scientists believe this will develop into a vast crack running from northern Ethiopia down to the middle of Mozambique. This could result in a 3,200-mile stretch of the east African coast, extending several hundred miles inland, splitting from the rest of the continent as the tectonic plate stretches, thins and eventually ruptures 'almost like soft plasticine'. This would leave a narrow ocean between continental Africa and a vast new island made up of present-day Somalia and large parts of what are now Ethiopia, Kenya, Tanzania and Mozambique. The Afar region of Ethiopia is a rare area where three tectonic rifts converge: the Main Ethiopian, Red Sea and Gulf of Aden rifts. Geologists had suspected that a 'hot upwelling' of molten mantle, often known as a plume, was rising up from between 620 and 1,700 miles deep, shooting upwards and melting the continental crust, weakening and thinning it. Researchers from the University of Southampton collected more than 130 samples of volcanic rock from the Afar region and Main Ethiopian Rift. They used modelling to understand the structure of the crust and mantle in the area. They found that beneath the Afar region there was an asymmetrical plume coming up out of the mantle, with patterns that differed in each of the three rifts. 'We found that the mantle beneath Afar is not uniform or stationary — it pulses, and these pulses carry distinct chemical signatures,' said Dr Emma Watts, lead author of the study who is now at Swansea University. 'These ascending pulses of partially molten mantle are channelled by the rifting plates above.' The results suggest the plume is 'pulsing like a heartbeat', said Tom Gernon, a professor of Earth science at Southampton. 'These pulses appear to behave differently depending on the thickness of the plate, and how fast it's pulling apart. In faster-spreading rifts like the Red Sea, the pulses travel more efficiently and regularly like a pulse through a narrow artery.' When a hot plume of magma rises from deep within the Earth it flows beneath the base of the tectonic plates and helps to 'focus volcanic activity to where the tectonic plate is thinnest'. 'This has profound implications for how we interpret surface volcanism, earthquake activity and the process of continental break up,' said Dr Derek Keir, a co-author of the study, which is published in the journal Nature Geoscience. Gernon said that part of the Afar region was about 120 metres below sea level and had been flooded by the sea several times in the past, including 80,000 years ago, as shown by salt deposits in the area. 'The formation of a fully developed ocean and mid-ocean ridge — that is, a plate tectonic feature where new ocean crust is created — in this region is likely to take several million years,' he said.
